Monocyte and macrophage activation by lipoteichoic acid is independent of alanine and is potentiated by hemoglobin

Journal of Immunology

Volumn 176, Issue 9, 2006, Pages 5567-5576

  Hasty, David L ^a,b   Meron Sudai, Shiri ^c   Cox, Kathleen H ^b   Nagorna, Tetyana ^b   Ruiz Bustos, Eduardo ^b,d   Losi, Elena ^b,e   Courtney, Harry S ^a,b   Mahrous, Engy A ^b   Lee, Richard ^b   Ofek, Itzhak ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

^d UNIVERSIDAD DE SONORA   (Mexico)

^e UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYTOKINE; HEMOGLOBIN; INTERLEUKIN 6; LIPOTEICHOIC ACID;

ABSORPTION SPECTROPHOTOMETRY; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BACTERIAL CELL WALL; CELL ACTIVITY; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE RELEASE; GRAM POSITIVE BACTERIUM; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; MONOCYTE; MONONUCLEAR CELL; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

EID: 33645975827     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.9.5567     Document Type: Article

References (53)

1. Ginsburg, I. 2002. Role of lipoteichoic acid in infection and inflammation. Lancet Infect. Dis. 2: 171-179.
2. Hashimoto, M., Y. Imamura, T. Morichika, K. Arimoto, O. Takeuchi, K. Takeda, S. Akira, K. Aoyama, T. Tamura, S. Kotani, et al. 2000. Cytokine-inducing macromolecular glycolipids from Enteracoccus hirae: improved method for separation and analysis of its effects on cellular activation. Biochem. Biophys. Res. Comm. 273: 164-169.
3. Hashimoto, M., J. Yasuoka, Y. Suda, H. Takada, T. Yoshida, S. Kotani, and S. Kusumoto. 1997. Structural feature of the major but not cytokine-inducing molecular species of lipoteichoic acid. J. Biochem. 121: 779-786.
4. Morath, S., A. Geyer, and T. Hartung. 2001. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 193: 393-397.
5. Morath, S., A. Stadelmaier, A. Geyer, R. R. Schmidt, and T. Hartung. 2002. Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J. Exp. Med. 195: 1635-1640.
6. Morath, S., A. Geyer, I. Spreitzer, C. Hermann, and T. Hartung. 2002. Structural decomposition and heterogeneity of commercial lipoteichoic acid preparations. Infect. Immun. 70: 938-944.
7. Mancuso, G., F. Tomasello, I. Ofek, and G. Teti. 1994. Anti-lipoteichoic acid antibodies enhance release of cytokines by monocytes sensitized with lipoteichoic acid. Infect. Immun. 62: 1470-1473.
8. Gargir, A., I. Ofek, D. L. Hasty, H. Tsubery, Y. Keisari, and A. Nissim. 2001. Inhibition of antibody-dependent stimulation of lipoteichoic acid-sensitized human monocytes and macrophages by polyglycerolphosphate- reactive peptides. J. Leukocyte Biol. 70: 537-542.
9. Brown, G. D., and S. Gordon. 2002. Phagocytes and anti-infective immunity. In Immunology of Infectious Diseases, S. H. E. Kaufmann, A. Sher and R. Ahmed, eds. ASM Press, Washington, D.C., pp. 79-91.
10. Schröder, N. W., S. Morath, C. Alexander, L. Hamann, T. Hartung, U. Zahringer, U. B. Gobel, J. R. Weber, and R. R. Schumann. 2003. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD 14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 278: 15587-15594.
11. Opitz, B., N. W. Schroder, I. Spreitzer, K. S. Michelsen, C. J. Kirschning, W. Hallatschek, U. Zahringer, T. Hartung, U. B. Gobel, and R. R. Schumann. 2001. Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-κB translocation. J. Biol. Chem. 276: 22041-22047.
12. Yoshimura, A., E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski, and D. Golenbock. 1999. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163: 1-5.
13. Ellingsen, E. A., S. Morath, T. H. Flo, A. B. Schromm, T. Hartung, C. Thiemermann, T. Espevick, D. T. Golenbock, S. J. Foster, R. Solberg, et al. 2002. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14. Med. Sci. Monit. 8: BR149-BR156.
14. Dunne, D. W., D. Resnick, J. Greenberg, M. Krieger, and K. A. Joiner. 1994. The type I macrophage scavenger receptor binds to Gram-positive bacteria and recognizes lipoteichoic acid. Proc. Natl. Acad. Sci. USA 91: 1863-1867.
15. Greenberg, J. W., W. Fischer, and K. A. Joiner. 1996. Influence of lipoteichoic acid structure on recognition by the macrophage scavenger receptor. Infect. Immun. 64: 3318-3325.
16. van de Wetering, J. K., M. van Eijk, L. M. van Golde, T. Hartung, J. A. van Strijp, and J. J. Batenburg. 2001. Characteristics of surfactant protein A and D binding to lipoteichoic acid and peptidoglycan, 2 major cell wall components of Gram-positive bacteria. J. Infect. Dis. 184: 1143-1151.
17. Lynch, N. J., S. Roscher, T. Hartung, S. Morath, M. Matsushita, D. N. Maennel, M. Kuraya, T. Fujita, and W. J. Schwaeble. 2004. L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement. J. Immunol. 172: 1198-1202.
18. Hermann, C., I. Spreitzer, N. W. J. Schröder, S. Morath, M. D. Lehner, W. Fischer, C. Schütt, R. R. Schumann, and T. Hartung. 2002. Cytokine induction by purified lipoteichoic acids from various bacterial species-role of LBP, sdsCD14, CD14 and failure to induce IL-12 and subsequent IFN-γ release. Eur. J. Immunol. 32: 541-551.
19. Grunfeld, C., M. Marshall, J. K. Shigenaga, A. H. Moser, P. Tobias, and K. R. Feingold. 1999. Lipoproteins inhibit macrophage activation by lipoteichoic acid. J. Lipid Res. 40: 245-252.
20. Kazmi, S. U., R. Kansal, R. K. Aziz, M. Hooshdaran, A. Norrby-Teglund, D. E. Low, A.-B. Halim and M. Kotb. 2001. Reciprocal, temporal expression of SpeA and SpeB by invasive M1T1 group A streptococcal isolates in vivo. Infect. Immun. 69: 4988-4995.
21. Maguin, E., H. Prévost, S. D. Ehrlich, and A. Gruss. 1996. Efficient insertional mutagenesis in lactococci and other Gram-positive bacteria. J. Bacteriol. 178: 931-935.
22. Neuhaus, F. C., and J. Baddiley. 2003. A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in Gram-positive bacteria. Microbiol. Mol. Biol. Rev. 67: 686-723.
23. Peshel, A. M. Otto, R. W. Jack, H. Kalbacher, G. Jung, and F. Götz. 1999. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 274: 8405-8410.
24. Poyart, C., M. C. Lamy, C. Boumaila, F. Fiedler, and P. Trieu-Cot. 2001. Regulation of D-alanyl-lipoteichoic acid biosynthesis in Streptococcus agalactiae involves a novel two-component regulatory system. J. Bacteriol. 183: 6324-6334.
25. Abachin, E., C. Poyart, E. Pelligrini, E. Milohanic, F. Fiedler, P. Berche, and P. Trieu-Cuot. 2002. Formation of D-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol. Microbiol. 43: 1-14.
26. Grangette, C., S. Nutten, E. Palumbo, S. Morath, C. Hermann, J. Dewulf, B. Pot, T. Hartung, P. Hols, and A. Mercenier. 2005. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc. Natl. Acad. Sci. USA 102: 10321-10326.
27. Steen, A., E. Palumbo, M. Deghorain, P. S. Cocconcelli, J. Delcour, O. P. Kuipers, J. Kok, G. Buist, and P. Hols. 2005. Autolysis of Lactococcus lactis is increased upon D-alanine depletion of peptidoglycan and lipoteichoic acids. J. Bacteriol. 187: 114-124.
28. Gao, J. J., Z. Xue, E. G. Zuvanich, K. R. Haghi, and D. C. Morrison. 2001. Commercial preparations of lipoteichoic acid contain endotoxin that contributes to activation of mouse macrophages in vitro. Infect. Immun. 69: 751-757.
29. Batley, M., J. W. Redmond, and A. J. Wicken. 1987. Nuclear magnetic resonance spectra of lipoteichoic acid. Biochim. Biophys. Acta 901: 127-137.
30. Ofek, I., E. H. Beachey, W. Jefferson and G. L. Campbell. 1975. Cell membrane-binding properties of group a streptococcal lipoteichoic acid. J. Exp. Med. 141: 990-1003.
31. Beachey, E. H., and I. Ofek. 1976. Epithelial cell-binding of group A streptococci by lipoteichoic acid on fimbriae denuded of M protein. J. Exp. Med. 143: 759-771.
32. Simpson, W. A., I. Ofek, and E. H. Beachey. 1980. Binding of streptococcal lipoteichoic acid to the fatty acid binding sites on serum albumin. J. Biol. Chem. 255: 6092-6097.
33. Winterbourn, C. C. 1990. Oxidative reactions of hemoglobin. Methods Enzymol. 186: 265-272.
34. Chiang, T. M., M. L. Alkan, and E. H. Beachey. 1979. Binding of lipoteichoic acid of group A streptococci to isolated human erythrocyte membranes. Infect. Immun. 26: 316-321.
35. Goldmann, O., G. S. Chhatwal, and E. Medina. 2003. Immune mechanisms underlying host susceptibility to infection with group A streptococci. J. Infect. Dis. 187: 854-861.
36. Kaca, W., R. I. Roth and J. Levin. 1994. Hemoglobin, a newly recognized lipopolysaccharide (LPS)-binding protein that enhances LPS biological activity. J. Biol. Chem. 269: 25078-25084.
37. Jürgens, G., M. Müller, M. H. J. Koch and K. Brandenburg. 2001. Interaction of hemoglobin with enterobacterial lipopolysaccharide and lipid A. Eur. J. Biochem. 268: 4233-4242.
38. Fischer, W., S. Markwitz, and H. Labischinski. 1997. Small-angle X-ray scattering analysis of pneumococcal lipoteichoic acid phase structure. Eur. J. Biochem. 244: 913-917.
39. Bhakdi, S., T. Klonisch, P. Nuber, and W. Fischer. 1991. Stimulation of monokine production by lipoteichoic acids. Infect. Immun. 59: 4614-4620.
40. Deininger, S., A. Stadelmaier, S. von Aulock, S. Morath, R. R. Schmidt, and T. Hartung. 2003. Definition of structural prerequisites for lipoteichoic acid-inducible cytokine induction by synthetic derivatives. J. Immunol. 170: 4134-4138.
41. von Aulock, S., N. W. J. Schröder, S. Traub, K. Gueinzius, E. Lorenz, T. Hartung, R. R. Schumann, and C. Hermann. 2004. Heterozygous toll-like receptor 2 polymorphism does not affect lipoteichoic acid-induced chemokine and inflammatory response. Infect. Immun. 72: 1828-1831.
42. Henneke, P., S. Morath, S. Uematsu, S. Weichen, M. Pritzenmaier, O. Takeuchi, A. Müller, C. Poyart, S. Akira, R. Berner, et al. 2005. Role of lipoteichoic acid in the phagocyte response to group B Streptococcus. J. Immunol. 174: 6449-6455.
43. Roth, R. I. 1994. Hemoglobin enhances the production of tissue factor by endothelial cells in response to bacterial endotoxin. Blood 83: 2860-2865.
44. Su, D., R. I. Roth, M. Yoshida, and J. Levin. 1997. Hemoglobin increases mortality from bacterial endotoxin. Infect. Immun. 65: 1258-1266.
45. Su, D., R. I. Roth, and J. Levin. 1999. Hemoglobin infusion augments the tumor necrosis factor response to bacterial endotoxin (lipopolysaccharide) in mice. Crit. Care Med. 27: 771-778.
46. Yang, H., H. Wang, T. R. Bernik, S. Ivanova, H. Wang, L. Ulloa, J. Roth, J. W. Eaton, and K. J. Tracey. 2002. Globin attenuates the innate immune re-sponse to endotoxin. Shock 17: 485-490.
47. Brandenburg, K., P. Garidel, J. Andrä, G. Jürgens, M. Müller, A. Blume, M. H. J. Koch, and J. Levin. 2003. Cross-linked hemoglobin converts endotoxically inactive pentaacyl endotoxins into a physiologically active conformation. J. Biol. Chem. 278: 47660-47669.
48. Joseph, R., and G. D. Shockman. 1975. Synthesis and excretion of glycerol teichoic acid during growth of two streptococcal species. Infect. Immun. 12: 333-338.
49. Alkan, M. L., and E. H. Beachey. 1978. Excretion of lipoteichoic acid by group A streptococci: influence of penicillin on excretion and loss of ability to adhere to human oral mucosal cells. J. Clin. Invest. 61: 671-677.
50. Home, D., and A. Tomasz. 1979. Release of lipoteichoic acid from Streptococcus sanguis: stimulation of release during penicillin treatment. J. Bacteriol. 137: 1180-1184.
51. Leon, O., and C. Panos. 1990. Streptococcus pyogenes clinical isolates and lipoteichoic acid. Infect. Immun. 58: 3779-3787.
52. Schneider, O., U. Michel, G. Zysk, O. Dubuis, and R. Nau. 1999. Clinical outcome in pneumococcal meningitis correlates with CSF lipoteichoic acid concentrations. Neurology 53: 1584-1587.
53. Wang, J. E., M. K. Dahle, M. McDonald, S. J. Foster, A. O. Aasen, and C. Thiemermann. 2003. Peptidoglycan and lipoteichoic acid in Gram-positive bacterial sepsis: receptors, signal transduction, biological effects, and synergism. Shock 20: 402-414.